# TIL (Instil Bio, Inc.) - SEC EDGAR Financial Statements

> Instil Bio, Inc. reported $195.6M in total assets and a net loss of $84.42M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TIL
- Markdown: https://convexityos.com/fundamentals/TIL.md
- SEC CIK: 0001789769
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001789769&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$29.49M | Operating profit |
| Net Income | FY 2025 | -$84.42M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$12.45 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $62.07M | Total debt: $2.10M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $0 | $138K |
| Research & Development | $24.74M | $11.84M | $39.60M | $141.1M | $107.3M | $19.40M |
| Total Operating Expenses | $80.27M | $73.54M | $159.2M | $226.5M | $155.6M | $33.78M |
| **Operating Income** | -$80.27M | -$73.54M | -$159.2M | -$226.5M | -$155.6M | -$33.64M |
| **EBITDA** | -$79.74M | -$69.93M | -$154.4M | -$220.5M | -$152.8M | -$33.39M |
| Interest Income | $3.86M | $6.99M | $8.87M | $3.65M | $80K | -- |
| Interest Expense | $5.96M | $8.99M | $5.21M | $1.88M | $0 | -- |
| Income Before Tax | -$71.37M | -$74.14M | -$156.1M | -$225.2M | -$156.8M | -$37.59M |
| Income Tax Expense | $0 | -- | $0 | -$2.07M | $39K | $151K |
| **Net Income** | -$71.37M | -$74.14M | -$156.1M | -$223.2M | -$156.8M | -$37.74M |
| Basic EPS | -$10.71 | -$11.39 | -$24.00 | -$34.46 | -$29.60 | -$47.20 |
| **Diluted EPS** | -$10.71 | -$11.39 | -$24.00 | -$34.46 | -$29.60 | -$47.20 |
| Basic Shares Outstanding | 6.7M | 6.5M | 6.5M | 6.5M | 5.3M | 799.9K |
| Diluted Shares Outstanding | 6.7M | 6.5M | 6.5M | 6.5M | 5.3M | 799.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $233K | $270K | $669K | $3.50M | $9.13M | $6.74M | $5.37M | $1.10M |
| Total Operating Expenses | $5.99M | $6.16M | $7.63M | $9.72M | $15.47M | $23.44M | $30.56M | $11.82M |
| **Operating Income** | -$5.99M | -$6.16M | -$7.63M | -$9.72M | -$15.47M | -$23.44M | -$30.56M | -$11.82M |
| **EBITDA** | -$5.26M | -$5.91M | -$7.62M | -$9.71M | -$15.46M | -$23.43M | -$30.06M | -$11.08M |
| Interest Income | $615K | $632K | $678K | $746K | $893K | $1.04M | $1.18M | $1.35M |
| Interest Expense | $1.55M | $1.58M | $1.55M | $1.57M | $1.58M | $1.58M | $1.10M | $3.00M |
| **Net Income** | -$4.23M | -$4.42M | -$4.37M | -$71.40M | -$13.59M | -$21.39M | -$28.51M | -$11.89M |
| Basic EPS | -$0.62 | -$0.65 | -$0.64 | -- | -$2.01 | -$3.24 | -$4.32 | -- |
| **Diluted EPS** | -$0.62 | -$0.65 | -$0.64 | -- | -$2.01 | -$3.24 | -$4.32 | -- |
| Basic Shares Outstanding | 6.8M | 6.8M | 6.8M | -- | 6.8M | 6.6M | 6.5M | -- |
| Diluted Shares Outstanding | 6.8M | 6.8M | 6.8M | -- | 6.8M | 6.6M | 6.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.64M | $8.80M | $9.20M | $43.72M | $37.59M | $241.7M |
| Short-Term Investments | $69.49M | -- | $141.2M | $217.2M | $416.5M | $0 |
| **Cash & Short-Term Investments** | $76.13M | $8.80M | $150.4M | $260.9M | $454.1M | $241.7M |
| Other Current Assets | $148K | $959K | $2.60M | -- | -- | $70K |
| **Total Current Assets** | $192.4M | $124.5M | $160.8M | $269.4M | $464.0M | $246.1M |
| Property, Plant & Equipment, Net | $126K | $129.4M | $138.7M | $196.9M | $122.0M | $55.34M |
| Goodwill | -- | -- | -- | $0 | $5.72M | $5.72M |
| Long-Term Investments | $0 | $0 | $23.16M | $0 | -- | -- |
| Other Non-Current Assets | $4.07M | $4.49M | $639K | $3.41M | $8.14M | $1.71M |
| **Total Non-Current Assets** | $12.09M | $139.1M | $164.9M | $212.8M | $146.0M | $72.87M |
| **Total Assets** | $204.5M | $263.6M | $325.6M | $482.1M | $610.0M | $319.0M |
| Accounts Payable | $779K | $659K | $1.21M | $2.36M | $5.57M | $3.50M |
| Other Current Liabilities | -- | $0 | $190K | $592K | $386K | $281K |
| **Total Current Liabilities** | $7.03M | $7.90M | $10.56M | $32.79M | $41.36M | $13.28M |
| Other Non-Current Liabilities | $8.0K | $83K | $80K | $332K | $20K | $0 |
| **Total Non-Current Liabilities** | $84.81M | $86.23M | $89.24M | $85.73M | $13.43M | $13.36M |
| **Total Liabilities** | $91.84M | $94.13M | $99.80M | $118.5M | $54.78M | $26.64M |
| **Total Debt (incl. Leases)** | $372K | $2.70M | $4.63M | $7.55M | -- | -- |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$727.7M | -$655.1M | -$581.0M | -$424.9M | -$201.7M | -$44.92M |
| Accumulated Other Comp. Income | -$583K | -$228K | -$348K | -$493K | -$87K | -$283K |
| **Total Stockholders' Equity** | $112.7M | $168.3M | $225.8M | $363.6M | $555.2M | -$39.60M |
| Total Equity | $112.7M | $168.3M | $225.8M | $363.6M | $555.2M | -$39.60M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.54M | $5.54M | $5.02M | $6.64M | $5.80M | $7.69M | $15.37M | $8.80M |
| Short-Term Investments | $59.53M | -- | -- | $69.49M | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $62.07M | $5.54M | $5.02M | $76.13M | $5.80M | $7.69M | $15.37M | $8.80M |
| Other Current Assets | $0 | $76K | $143K | $148K | $164K | $154K | $192K | $959K |
| **Total Current Assets** | $65.51M | $73.11M | $189.7M | $192.4M | $196.3M | $207.4M | $219.3M | $124.5M |
| Property, Plant & Equipment, Net | $111.1M | $111.8M | $112K | $126K | $138K | $150K | $162K | $129.4M |
| Long-Term Investments | $4.64M | -- | -- | $0 | $3.44M | $11.66M | $7.19M | $0 |
| Other Non-Current Assets | $3.83M | $3.91M | $3.99M | $4.07M | $4.15M | $11.20M | $10.07M | $4.49M |
| **Total Non-Current Assets** | $130.1M | $126.1M | $12.13M | $12.09M | $15.50M | $23.60M | $18.18M | $139.1M |
| **Total Assets** | $195.6M | $199.2M | $201.8M | $204.5M | $211.8M | $231.0M | $237.4M | $263.6M |
| Accounts Payable | $363K | $795K | $793K | $779K | $928K | $523K | $286K | $659K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $6.29M | $6.29M | $7.46M | $7.03M | $5.70M | $13.85M | $7.23M | $7.90M |
| Other Non-Current Liabilities | $0 | $0 | $8.0K | $8.0K | $88K | $90K | $85K | $83K |
| **Total Non-Current Liabilities** | $86.79M | $87.03M | $85.01M | $84.81M | $85.65M | $85.46M | $85.31M | $86.23M |
| **Total Liabilities** | $93.08M | $93.32M | $92.46M | $91.84M | $91.35M | $99.32M | $92.54M | $94.13M |
| **Total Debt (incl. Leases)** | $2.10M | $2.23M | $186K | $372K | $305K | $462K | $2.44M | $2.70M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$740.7M | -$736.5M | -$732.1M | -$727.7M | -$718.3M | -$704.7M | -$683.3M | -$655.1M |
| Accumulated Other Comp. Income | -$672K | -$587K | -$532K | -$583K | -$612K | -$805K | -$451K | -$228K |
| **Total Stockholders' Equity** | $102.6M | $105.9M | $109.3M | $112.7M | $118.9M | $130.2M | $143.4M | $168.3M |
| Total Equity | $102.6M | $105.9M | $109.3M | $112.7M | $118.9M | $130.2M | $143.4M | $168.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$71.37M | -$74.14M | -$156.1M | -$223.2M | -$156.8M | -$37.74M |
| Depreciation & Amortization | $534K | $3.61M | $4.76M | $5.99M | $2.75M | $256K |
| Stock-Based Compensation | $8.69M | $17.26M | $18.17M | $30.44M | $26.20M | $1.71M |
| Change in Payables | $116K | -$556K | -$1.13M | -$1.81M | $3.86M | -$1.05M |
| **Operating Cash Flow** | -$36.62M | -$55.70M | -$82.03M | -$180.2M | -$122.1M | -$29.62M |
| Capital Expenditure | -- | $0 | -$20.66M | -$84.59M | -$57.83M | -$50.82M |
| **Free Cash Flow** | -- | -$55.70M | -$102.7M | -$264.8M | -$180.0M | -$80.43M |
| Acquisitions, Net | -- | -- | -- | -- | $0 | -$306K |
| Purchases of Investments | -$100.9M | -$134.0M | -$301.5M | -$665.0M | -$1.11B | $0 |
| **Investing Cash Flow** | $25.48M | $53.97M | $41.13M | $114.5M | -$474.4M | -$51.12M |
| Common Stock Issued | $6.61M | $0 | -- | -- | -- | -- |
| **Financing Cash Flow** | $7.29M | $1.75M | $8.08M | $71.89M | $393.2M | $313.0M |
| **Net Change in Cash** | -$3.85M | $33K | -$32.82M | $6.26M | -$203.4M | $232.3M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.23M | -$4.42M | -$4.37M | -$71.40M | -$13.59M | -$21.39M | -$28.51M | -$11.89M |
| Depreciation & Amortization | $723K | $248K | $12K | $12K | $12K | $12K | $498K | $741K |
| Stock-Based Compensation | $984K | $1.04M | $985K | $1.61M | $1.77M | $1.82M | $3.50M | $4.50M |
| Change in Payables | -$432K | $0 | $17K | -$148K | $403K | $237K | -$376K | -$522K |
| **Operating Cash Flow** | -$2.40M | -$4.64M | -$1.34M | -$7.08M | -$10.56M | -$14.79M | -$4.20M | -$10.56M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$10.56M |
| Purchases of Investments | -$20.75M | -$17.51M | -$22.32M | -$17.39M | -$6.56M | -$38.71M | -$38.19M | -$27.32M |
| **Investing Cash Flow** | -$155K | $5.29M | -$317K | $7.82M | $8.45M | -$400K | $9.61M | $13.00M |
| **Financing Cash Flow** | -$300K | $0 | $0 | $0 | $378K | $6.68M | $232K | $1.60M |
| **Net Change in Cash** | -$2.86M | $649K | -$1.65M | $742K | -$1.73M | -$8.51M | $5.65M | $4.04M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -24379.7% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -27346.4% |
| Return on Equity (ROE) | -63.3% | -44.1% | -69.1% | -61.4% | -28.2% | -- |
| Return on Assets (ROA) | -34.9% | -28.1% | -47.9% | -46.3% | -25.7% | -11.8% |
| Current Ratio | 27.37x | 15.76x | 15.22x | 8.22x | 11.22x | 18.53x |
| Quick Ratio | 10.83x | 1.12x | 14.24x | 7.96x | 10.98x | 18.20x |
| Debt to Equity | 0.00x | 0.02x | 0.02x | 0.02x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -100.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -82.3% | -88.6% | -101.3% | -119.7% | -63.4% | -65.2% | -54.6% | -44.1% |
| Return on Assets (ROA) | -43.1% | -47.1% | -54.9% | -66.0% | -35.6% | -36.7% | -33.0% | -28.1% |
| Current Ratio | 10.42x | 11.62x | 25.44x | 27.37x | 34.45x | 14.97x | 30.33x | 15.76x |
| Quick Ratio | 9.87x | 0.88x | 0.67x | 10.83x | 1.02x | 0.56x | 2.13x | 1.12x |
| Debt to Equity | 0.02x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
